Cost Considerations for Medical Device Molding

Over the course of nearly two decades, I’ve been involved in the development of various components for a wide array of medical devices. From insulin pumps to surgical tools for cataract procedures, enteral feeding systems, and diagnostic equipment, the range of projects has been extensive. As medical molders, our role often involves collaborating with clients to enhance design for manufacturing efficiency, part quality, and cost-effectiveness. Today, our focus has shifted towards supporting high-volume automated manufacturing processes where cost optimization is paramount, particularly when producing tens of millions of parts annually from a single injection mold. It is crucial to identify mutually beneficial strategies to reduce the overall cost of medical devices in a sustainable manner, moving beyond traditional cost-cutting models.

UPFRONT COLLABORATION

Upfront collaboration with your supplier(s) is certainly important, especially when it comes to gate optimization, runner type, mold cavitation, as these components will lead to cost improvement. Equally important to the OEM / Supplier partnership, is collaboration within the various departments of your company. Too often, I’ve seen when R&D becomes siloed, and the scope of the project begins to drift after numerous iterations, design changes, material trials, etc.

Although cost impacts all divisions within an organization, the reality is, I’ve seen this first-hand R&D may have different wants & needs than someone in a procurement role who is historically tasked with cost savings. For this reason, I believe it’s important to have a representative from your procurement or operations team working along with R&D to ensure the cost of the device remains within the original scope. If changes to assembly methods, raw materials, or labor led to increased costs, it’s critical to maintain traceability throughout the development process. This ensures a clear understanding of the factors driving these unforeseen expenses.

COST DRIVERS FOR MEDICAL INJECTION MOLDERS

When quoting any injection molded component, there are numerous inputs we account for. These include raw material, labor, cycle time, packaging, mold cavitation, scrap, and profit. Of course, some of these inputs have a greater impact than others, so I want to focus on the main cost drivers that have the largest influence on overall part cost. Most often, mold cavitation will have the largest immediate impact on cost, but mold cavitation is largely driven off the volume of the device. Therefore, I’m not going to spend too much time on mold cavitation, since again, volume (and sometimes part complexity) will drive that need.

Raw Material

There are literally endless types of medical-grade resins on the market today, many of which can even be customized for a specific application. While it’s great that so many options exist today, there are certainly some hidden “red flags” to be on the lookout for.

Cycle Time

Cycle time is another leading contributor to overall part cost which is usually impacted most by gate location (and type), along with wall thickness.

Labor

I’ve seen labor increase the cost of a medical device for numerous reasons. These can range from secondary operations (i.e. pad printing), increased inspection, special packaging, etc. The expanded use of automation has certainly helped address what I have noted above, but even with automation, there are added costs to consider. Bottom line, to be cost-competitive in the United States, we need to look for any / all opportunities where we have a single person assigned to a specific operation, often referred to a “full operator”.

In summary, these are just a few of the examples we’ve encountered over the years that have an impact on the molded part cost. I encourage anyone who is involved in the development and manufacturing of your medical device to engage your supplier(s) early and often. Have a transparent conversation about your pricing goals and what it would take to achieve them. Revalidating existing devices with new materials, gate locations, or designs poses a significant challenge. Despite the complexity of this task, exploring these opportunities is essential as they can uncover valuable low-hanging fruit!

ABOUT THE AUTHOR

Dan Snyder is the Technical Sales Manager and joined Plastikos in 2008. He holds B.S in Plastics Engineering Technology from Penn State University. Dan’s primary role at Plastikos is working directly with medical device OEM’s on new & existing devices, providing technical support throughout all phases of the lifecycle of the device. Outside of work, Dan is an avid outdoorsman’s enjoying mountain biking, skiing, hunting, fishing, and coaching his two sons in sports.